We present a new method for quantitative determination of alkaline phosphatase isoenzymes. This method consists of electrophoretic separation on cellulose acetate membranes, special fixation technique to avoid elution and diffusion of enzyme protein during incubation, specific staining, and quantitative evaluation by densitometric measurement. We highly recommend the procedure for routine clinical laboratory use. In all normal individuals we observe two isoenzymes of hepatic origin and one isoenzyme each of osseous, intestinal, and biliary origin. The isoenzymes of alkaline phosphatase [orthophosphoric-monoester phosphohydrolase (alkaline optimum), EC 3.1.3.1] in human serum originate from several organs, such as liver, bone, intestine, placenta, tumors, and the biliary tract (1) (2)(3)(4)(5). In clinical chemistry total alkaline phosphatase activity is usually measured, and so it is impossible to differentiate between hepatobiliary, bone, or intestinal diseases. Therefore it is of considerable diagnostic relevance to find out which isoenzyme of alkaline phosphatase (API) is showing increased activity under pathological conditions. Several methods have been reported for differentiating and determining API: heat inactivation (6), inhibition by L-phenylalanine (7), L-homoarginine (8) and urea (9) (27,28). Nevertheless, none of these is ideally practicable in a routine clinical laboratory, because either separation of API is incomplete or quantitative evaluation is not possible. With cellulose acetate there is the special problem of how to avoid elution and diffusion of the enzyme protein during incubation (33, 33a).
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We present a new method for quantitative determination of alkaline phosphatase isoenzymes. This method consists of electrophoretic separation on cellulose acetate membranes, special fixation technique to avoid elution and diffusion of enzyme protein during incubation, specific staining, and quantitative evaluation by densitometric measurement. We highly recommend the procedure for routine clinical laboratory use. In all normal individuals we observe two isoenzymes of hepatic origin and one isoenzyme each of osseous, intestinal, and biliary origin.
Quantitative normal values are presented. Precision of the method is calculated, the CV being <10%. The exactness of densitometric quantification is proved by comparison with kinetic assay of alkaline phosphatase isoenzymes by use of an elution method. Clinical implications of alkaline phosphatase isoenzymograms are reported and discussed in detail.
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The isoenzymes of alkaline phosphatase [orthophosphoric-monoester phosphohydrolase (alkaline optimum), EC 3.1.3.1] in human serum originate from several organs, such as liver, bone, intestine, placenta, tumors, and the biliary tract (1) (2) (3) (4) (5) . In clinical chemistry total alkaline phosphatase activity is usually measured, and so it is impossible to differentiate between hepatobiliary, bone, or intestinal diseases. Therefore it is of considerable diagnostic relevance to find out which isoenzyme of alkaline phosphatase (API) is showing increased activity under pathological conditions. Several methods have been reported for differentiating and determining API: heat inactivation (6), inhibition by L-phenylalanine (7), L-homoarginine (8) 
Materials and Methods
All chemicals used were of analytical grade and were purchased from Merck AG, Darmstadt, if not indicated otherwise. Total alkaline phosphatase activity was determined according to Hausamen et al. (29) To identify the different API bands of serum, specimens of human organs (liver, bone, intestine, choledochus), obtained postmortem, were extracted with butanol as described elsewhere (31), with slight modifications, followed by ultracentrifugation (35 mm at 50000Xg).
To demonstrate pathological API patterns, we used serum of patients. Normal values for serum API were established from results for sera from 71 apparently healthy blood donors, which we statistically evaluated (32). For the electrophoretic separations we used the Beckman Microzone#{174} cell (R 101, R 200) and Duostat RD power supply, with cellulose acetate membranes (Millipore). We applied 0.25 il of serum (Beckman  sample applicator No. 324 399). Sodium diethylbarbiturate (75 mmol/liter, pH 8.6) was used as buffer. Applying 5 mA constant current (1.16 mA/cm), a 90-mm electrophoresis was performed with a voltage of 260 V, which decreased to 160 V during the separation (20 to 14.6 V/cm). After the separation, the membranes were stained either for API according to the method reported in this paper or (for comparison) for protein with Ponceau S according to Beckman Instruction Manual RM-IM-3.
API staining
procedure.
After electrophoretic separation, place the membranes into the following successive baths:
1. Fixative bath: 10 mm in a mixture of 70 ml of ethanol (96%) and 30 ml of a 0.33 mol/liter lead acetate stock solution.
2. Rinsing bath: 10 mm in a saturated solution of sodium acetate.
3. Incubation bath (pH 10.2): 120 mm in a mixture of 90 ml of saturated sodium acetate solution, 10 ml of 1 mol/liter tris(hydroxymethyl)aminomethane stock solution, 2 ml of 57 mmol/liter sodium naphthyl-1-phosphate stock solution, and 2 ml of a 12.5 mmol/liter magnesium chloride stock solution.
4. Staining bath: 25 mm in 100 ml of distilled water plus 1 ml of 1 mol/liter tris(hydroxymethyl)aminomethane stock solution plus 1 ml of dye stock solution [1 g of 4-aminodiphenylamine-diazo-sulfate (Vanamin-Blau B#{174}) in 100 ml of dimethylformamide, filtered].
5. Destaining bath: two 10-mm soaks in an equivolume mixture of ethanol/water.
Then place the membrane on a glass plate and dry it for 10 mm at 56 #{176}C, put it in a plastic bag (Beckman Fig. 1 ing.
We evaluated the isoenzyme bands quantitatively with the Beckman densitometer R-110 and Digital Integrator R-111, at 546 nm; values are given in U/liter based on total enzyme activity. Evaluation of bone API was done by using a stencil according to the isoenzyme migration distance (see Results and Discussion) .
Intermet hod comparison.
To ascertain that our quantitative results by this method were correct, we used an elution technique for comparison. After electrophoresis of 5 l of serum, part of the membrane was stained for protein and the remainder was cut in segments according to the protein pattern. The enzyme protein was eluted by shaking with distilled water in a test tube for 2 h. After removing the membrane, the sample was evaporated (Rotavapor, BUchi) and the residue resuspended in 1.8 ml of diethanolamine buffer and 0.2 ml buffer-substrate solution (Merckotest#{174}) and the enzymatic activity was estimated without delay.
Results and Discussion

Technical Problems
Electrophoress for 90 mm provided optimal isoenzyme separation for quantitative evaluation; a longer time resulted in more diffuse bands. A 5-mA constant current was applied to avoid heat formation in the membrane.
Endosmosis during electrophoresis contributes considerably to isoenzyme separation; that is why the sample is applied in the middle of the membrane.
The main problem in staining cellulose acetate membranes is to avoid elution and diffusion of enzyme protein during the incubation (33, 33a) . Up to now, enzyme staining on cellulose acetate membranes was not possible in a free medium (fluid substrate solution), because the enzyme protein could not be fixed in the cellulose acetate without destroying enzymatic activity (33, 33a is by no means a requisite for quantitative evaluation.
API Identification and Quantitative Normal Values
We determined the organs of origin of the API represented by the bands separated by this method by analysis of organ homogenates, of sera of patients with well-studied diseases (Figure 1) , by heat inactivation (6) and inhibitor studies (7, 8) , and by resistance to neuraminidase treatment (30) . According to these results ( Table 1 ) the API bands are identified and referred to as: band I, first liver isoenzyme; band II, bone isoenzyme; band III, second liver isoenzyme; band IV, intestinal isoenzyme; and band V as "physiological" biliary isoenzyme. The last two show some overlapping in their organ homogenate pattern ( Table 1) .
The results of the inhibitor studies correspond well to results reported in the literature (1, 26) , but both the isoenzymes of hepatic origin show differences in both heat inactivation (26) and in inhibition by L-phenylalanine. The second liver isoenzyme is activated by Lphenylalanine and that is in contrast to the literature Table 2 . Bone and liver isoenzymes follow a log-normal (geometrical) distribution, whereas intestinal and "physiological" biliary isoenzyme show a biphasic distribution attributable to blood-group dependency.
It is already well known that the intestinal isoenzyme is dependent on blood groups, Lewis factor, and ABH secretor status Table 2 ; Figures 2, 3d, 3e) . The same applies to the "physiological" biliary isoenzyme (Table  2; Figures 2, 3d, 3e), and this is a new observation, be- cause up to now only the presence of a "bile specific" isoenzyme has been reported (21, 36) in the serum of normal individuals. Because of some overlapping in the organ homogenate isoenzyme pattern with the intestinal isoenzyme ( Table 1) it cannot be clearly excluded that the "physiological" biliary isoenzyme in serum originates from intestine. Cha et al. (26) reported two intestinal isoenzyme bands in serum electrophoresed on cellulose acetate.
Both liver isoenzymes (bands I and III) are consistent constituents of all sera investigated. This consistency has never been observed before, although Moss (34) reported two main isoenzyme bands in liver homogenates. Some authors (14, 20, 25, 26) have observed two hepatic isoenzymes, but only in serum from patients with hepatobiliary diseases.
Quantitative Determination of
Isoenzyme from Bone Table 1 shows how far the various API migrate from the starting point, which we define as the point where the baseline and the tangent on the anodal limb of the first liver isoenzyme peak cross in the densitometric diagram. The migration distances of the API have been established from sera and are reasonably constant (Table 1) , which is an essential condition for quantitative evaluation, especially of the bone isoenzyme. We agree with other authors that this isoenzyme does not show a sharp band and that it is not discretely separated from the adjacent liver isoenzymes. That is why we have coped with the problem of quantitative evaluation of the bone isoenzyme by measuring the AP activity in the densitometric diagram (by using a stencil) within the space of 23.4 to 37.3 mm, counted from the starting point, as bone isoenzyme activity (Table 1) . Nordentoft-Jensen (28) used a similar principle. This method provides good and useful results, as for example in the case of a patient suffering from osteosarcoma but whose total serum alkaline phosphatase activity is normal ( Figures 2P, and 3f) .
Correlation between API Activities as Determined by Densitometric and Kinetic Measurement
To confirm the accuracy of the densitometrically evaluated relative activities, we compared them with the kinetically measured activities obtained after elution
(Materials and Methods).
From the data presented in Table 3 we can state that densitometric evaluation provides comparable results, even though different substrates (p-nitrophenylphosphate and sodium naphthyl-1-phosphate) were used in the two methods. Because both substrates have almost the same reactivity with API (37, 38) , and because of our results (Table 3) , it seems justified to express the densitometric values in terms of IUB units (U) of enzymatic activity per liter.
Replicate analyses (n = 16) of the same serum on the same date, with use of four different membranes yielded Precision a CV of 3.8% for the first liver isoenzyme and a CV of We established the precision of the quantitative API 7.2% for the second liver isoenzyme.
Three different sera were analyzed during 66 days (n = 14); the first eight analyses were done every third day and the rest at one-week intervals. The CV was 3.0,4.5, and 6.5%, respectively, for the first liver isoenzyme and 9.1, 9.8, and 11.6%, respectively, for the second liver isoenzyme.
API in Pathological Sera
The quantitative determination of API is very important for clinical interpretation; usually no new isoenzymes appear, but instead the normal isoenzyme pattern only changes quantitatively (Figures 1 and 3) . We frequently observe pathological isoenzyme values, even when total serum AP is still within the normal range ( Figures 2P and 3!) . In some cases additional isoenzymes can be observed in pathological samples: the "pathological" biliary isoenzyme (band Vp in Table 1 ; Figures 1 and 3a) , which is only seen in patients with cholestasis; a placental isoenzyme that can be distinguished in pregnancy (5); a special isoenzyme originating from a tumor can be seen in serum occasionally (1) ; and a "growth" isoenzyme, of unknown origin (17), may appear in serum from certain pediatric patients.
The changes of API activity correspond generally with the clinical diagnosis proven either by biopsy or autopsy (Figure 1) .
In liver diseases usually there is increased activity of both liver isoenzymes ( Figures 1 and 3b) ; further experiments are necessary, and are going on, to elucidate which of the liver isoenzymes may preferentially increase in certain liver diseases.
Often the intestinal isoenzyme is elevated in addition to the liver isoenzymes in chronic active hepatitis and liver cirrhosis (1, 3, 16) . Pathological values for the intestinal isoenzyme are also found in malabsorption In patients with intra-or extrahepatic cholestasis we observed, that, besides the increased activity of both hepatic isoenzymes, either the "physiological" biliary isoenzyme exceeds the normal range or a special isoenzyme appears, thus called "pathological" biliary isoenzyme (band Vp in Table 1 ; Figures 1 and 3a) . The occurrence of a special isoenzyme in cholestasis has been reported by several authors (2-4, 15, 17 the total alkaline phosphatase activity in serum was within the normal range (and thus lacks sufficient sensitivity).
Generally, it can be stated that estimation of total serum alkaline phosphatase activity is inferior to quantitative API determination and that the latter gives more subtle information; API determination might even be of importance for screening purposes. We believe, that this new technique for quantitative AP isoenzyme determination is utterly recommendable for use in the routine clinical laboratory and gives valuable, reliable results.
Large-scale, statistically examined tests are going on in our laboratory to further elucidate the diagnostic value of quantitative AP isoenzyme determination.
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